Eli Lilly under pressure: Can it solve GLP-1 supply squeeze?

Specific doses of Eli Lilly’s GLP-1 blockbuster drugs Mounjaro and Zepbound are currently facing a supply shortage, and frustrated patients are urging the pharma giant to act – fast.

Related Keywords

Canada ,India ,Vietnam ,Republic Of ,David Ricks ,Eli Lilly ,Vikram Shanbhag ,Nicolas Schmitz ,Lilly Mounjaro ,Lars Fruergaard ,Novo Nordisk Wegovy ,Novo Nordisk ,Dave Knapp ,Bloomberg ,Novo Holdings ,Bio Pharma ,Big Night ,Mounjaro User Dave Knapp ,Markets Amp Regulations ,Biopharma Culture ,Pipelines ,Emerging Markets ,Illy ,Obesity ,Diabetes ,